For immediate release
Nanoco Group PLC
("Nanoco", the "Group", or the "Company")
Transaction in Own Shares
and
Total Voting Rights
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform, announces that on 23rd August 2024, it purchased the following number of its ordinary shares of 10.0 pence each on the London Stock Exchange in accordance with the terms of the share buyback programme announced on 11th April 2024 (the "Buyback Programme").
| Date of purchase: | 23/08/2024 |
| Number of Ordinary Shares purchased: | 101,295 |
| Lowest price paid per Ordinary Share (pence): | 14.04 |
| Highest price paid per Ordinary Share (pence): | 14.04 |
| Volume weighted average price paid per Ordinary share (pence): | 14.04 |
Nanoco intends to cancel all of the purchased ordinary shares.
Following the cancellation of the ordinary shares purchased above, the Company will have 199,778,126 Ordinary Shares in issue. This figure represents the total voting rights in the Company and may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), the table below contains detailed information of the individual trades made by Cavendish Securities plc on behalf of the Company as part of the Buyback Programme.
| Transaction time | Number of shares purchased | Transaction price per share (pence) | Trading venue |
| 16:36:39 | 101,295 | 14.04 | XLON |
| | | | |
For further information, please contact:
| Nanoco Group plc: Brian Tenner, CEO Liam Gray, CFO & Company Secretary
| +44 (0)1928 761 404
|
| Cavendish Capital Markets Limited (Financial Adviser & Corporate Broker): Ed Frisby / George Lawson (Corporate Finance) Tim Redfern / Charlie Combe (Corporate Broking) Jasper Berry (Sales)
| +44 (0) 20 7220 0500
|
| Sodali & Co (Public Relations): Elly Williamson Pete Lambie Nanoco@sodali.com | +44 (0)7970 246 725 |
About Nanoco Group plc
Nanoco (LSE: NANO) is a nanomaterial production and licensing company, specialising in the production of its patented cadmium free quantum dots (CFQD®) and other patented nanomaterials for use in the electronics industries.
Founded in 2001 and headquartered in Runcorn, UK, Nanoco continues to build out a world-class, patent-protected IP portfolio alongside the scaling of the production for commercial orders.
Nanomaterials are materials with dimensions typically in the range 1 - 100 nm. Nanomaterials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nanomaterial that have size-dependent optical and electronic properties. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Sensor, Electronics and Display markets. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of display applications. Nanoco's HEATWAVE™ quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectrum, rendering them useful for applications including cameras and image sensors.
Nanoco is listed on the Main Market of the London Stock Exchange, holds the LSE's Green Economy Mark, and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.